This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License which permits noncommercial use and distribution provided the original author(s) and source are credited. (See https://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Kent DM, Saver JL, Kasner SE, et al. Evaluating Therapies to Prevent Future Stroke in Patients with Patent Foramen Ovale-Related Strokes — The SCOPE Study [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2023 Apr. doi: 10.25302/04.2023.RS.SCOPE2019001
Evaluating Therapies to Prevent Future Stroke in Patients with Patent Foramen Ovale-Related Strokes — The SCOPE Study [Internet].
Show detailsTable 1The RoPE Score and PASCAL Classifications
| RoPE score calculator a | ||
| Characteristic | Points | |
| No history of hypertension | 1 | |
| No history of diabetes | 1 | |
| No history of stroke or transient ischemic attack | 1 | |
| Nonsmoker | 1 | |
| Cortical infarct on imaging | 1 | |
| Age, y | ||
| 18-29 | 5 | |
| 30-39 | 4 | |
| 40-49 | 3 | |
| 50-59 | 2 | |
| 60-69 | 1 | |
| ≥70 | 0 | |
| Total RoPE score (sum of individual points) = ______ | ||
| PASCAL classification system b | ||
| High RoPE score (≥7) | High-risk PFO feature (LS and/or ASA)c | PFO-related stroke |
| Absent | Absent | Unlikely |
| Absent | Present | Possible |
| Present | Absent | |
| Present | Present | Probable |
Abbreviations: ASA, atrial septal aneurysm; LS, large shunt; PASCAL, PFO-Associated Stroke Causal Likelihood; PFO, patent foramen ovale; RoPE, Risk of Paradoxical Embolism.
aThe RoPE score assesses the probability that a PFO discovered in the setting of an otherwise-cryptogenic stroke was pathogenically related to the stroke rather than an incidental finding. The RoPE score ranges from 0 to 10, with scores of 0 to 3 indicating a negligible likelihood that the stroke is attributable to the PFO and a score of 10 indicating an approximately 90% probability that the stroke is attributable to the PFO.
bPASCAL combines the RoPE score with the presence or absence of high-risk PFO features to determine the likelihood that the PFO was causally related to the index stroke. See Appendix A2 for details on RoPE and Appendix A3 for details on PASCAL.
cASA is defined as ≥10 mm of excursion from midline. Large shunt size was defined in our database as >20 bubbles in the left atrium on transesophageal echocardiogram.
- Association of Atrial Septal Aneurysm and Shunt Size With Stroke Recurrence and Benefit From Patent Foramen Ovale Closure.[JAMA Neurol. 2022]Association of Atrial Septal Aneurysm and Shunt Size With Stroke Recurrence and Benefit From Patent Foramen Ovale Closure.Mas JL, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, Derumeaux G, Furlan AJ, Herrmann HC, Jüni P, et al. JAMA Neurol. 2022 Nov 1; 79(11):1175-1179.
- Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.[Stroke. 2020]Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.Kent DM, Saver JL, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Smalling RW, Jüni P, Mattle HP, Meier B, et al. Stroke. 2020 Oct; 51(10):3119-3123. Epub 2020 Sep 14.
- A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.[J Med Econ. 2024]A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.Kasner SE, Sondergaard L, Nakum M, Gomez Montero M, Hashim M, Landaas EJ. J Med Econ. 2024 Jan-Dec; 27(1):337-343. Epub 2024 Feb 29.
- Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.[Cochrane Database Syst Rev. 2015]Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C. Cochrane Database Syst Rev. 2015 Sep 8; 2015(9):CD009938. Epub 2015 Sep 8.
- Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.[Eur Heart J. 2013]Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A. Eur Heart J. 2013 Nov; 34(43):3342-52. Epub 2013 Jul 11.
- Table 1, The RoPE Score and PASCAL Classifications - Evaluating Therapies to Pre...Table 1, The RoPE Score and PASCAL Classifications - Evaluating Therapies to Prevent Future Stroke in Patients with Patent Foramen Ovale-Related Strokes — The SCOPE Study
Your browsing activity is empty.
Activity recording is turned off.
See more...